Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123292534 | 12329253 | 4 | F | 201507 | 20160705 | 20160503 | 20160824 | EXP | CA-HQ SPECIALTY-CA-2016INT000251 | INTERCHEM | 55.62 | YR | F | Y | 0.00000 | 20160824 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123292534 | 12329253 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | UNK | Y | 201749 | TABLET | |||||||||
| 123292534 | 12329253 | 2 | SS | ENBREL | ETANERCEPT | 1 | Subcutaneous | UNK | Y | 0 | |||||||||
| 123292534 | 12329253 | 3 | SS | CELEBREX | CELECOXIB | 1 | UNK | 0 | CAPSULE | ||||||||||
| 123292534 | 12329253 | 4 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 10 MG (5 MG, 2 IN 1 D) | Y | 0 | 5 | MG | TABLET | ||||||
| 123292534 | 12329253 | 5 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | UNK | Y | 0 | TABLET | |||||||||
| 123292534 | 12329253 | 6 | SS | LYRICA | PREGABALIN | 1 | UNK | 0 | |||||||||||
| 123292534 | 12329253 | 7 | SS | ARTHROTEC | DICLOFENAC SODIUMMISOPROSTOL | 1 | UNK | Y | 0 | TABLET | |||||||||
| 123292534 | 12329253 | 8 | SS | PREDNISONE. | PREDNISONE | 1 | UNK | Y | 0 | ||||||||||
| 123292534 | 12329253 | 9 | SS | NAPROSYN | NAPROXEN | 1 | UNK | Y | 0 | ||||||||||
| 123292534 | 12329253 | 10 | SS | APO-AMITRIPTYLINE | AMITRIPTYLINE HYDROCHLORIDE | 1 | UNK | Y | 0 | ||||||||||
| 123292534 | 12329253 | 11 | SS | VOLTAREN | DICLOFENAC SODIUM | 1 | UNK | Y | 0 | ||||||||||
| 123292534 | 12329253 | 12 | SS | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123292534 | 12329253 | 1 | Rheumatoid arthritis |
| 123292534 | 12329253 | 2 | Rheumatoid arthritis |
| 123292534 | 12329253 | 3 | Rheumatoid arthritis |
| 123292534 | 12329253 | 4 | Rheumatoid arthritis |
| 123292534 | 12329253 | 6 | Rheumatoid arthritis |
| 123292534 | 12329253 | 7 | Rheumatoid arthritis |
| 123292534 | 12329253 | 8 | Rheumatoid arthritis |
| 123292534 | 12329253 | 9 | Rheumatoid arthritis |
| 123292534 | 12329253 | 10 | Rheumatoid arthritis |
| 123292534 | 12329253 | 11 | Rheumatoid arthritis |
| 123292534 | 12329253 | 12 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123292534 | 12329253 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123292534 | 12329253 | Asthenia | |
| 123292534 | 12329253 | Drug ineffective | |
| 123292534 | 12329253 | Drug interaction | |
| 123292534 | 12329253 | Joint range of motion decreased | |
| 123292534 | 12329253 | Muscle spasms | |
| 123292534 | 12329253 | Pain | |
| 123292534 | 12329253 | Pain in jaw | |
| 123292534 | 12329253 | Product quality issue | |
| 123292534 | 12329253 | Rheumatoid arthritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123292534 | 12329253 | 1 | 2004 | 2015 | 0 | |
| 123292534 | 12329253 | 2 | 2010 | 201507 | 0 | |
| 123292534 | 12329253 | 4 | 20150724 | 201511 | 0 | |
| 123292534 | 12329253 | 7 | 2004 | 2010 | 0 | |
| 123292534 | 12329253 | 11 | 2004 | 2010 | 0 | |
| 123292534 | 12329253 | 12 | 2004 | 0 |